Irish scientists have developed a gene therapy treatment for glaucoma, following positive results in treating age-related macular degeneration (AMD). Glaucoma, a vision-threatening condition affecting millions worldwide, has limited treatment options. The new therapy, using an enhanced gene to boost mitochondrial function and reduce damage, showed promising results in animal and human cells. The researchers aim to translate these findings into clinical trials, with the potential to revolutionize glaucoma treatment. The team has founded Vzarii Therapeutics to advance the development of gene therapies for AMD and glaucoma, highlighting the significance of their work in improving patient outcomes.
Source link
Irish research holds promise in treating eye conditions
